News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA Lifts Block On Three Pliva Drugs
July 7, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, July 7 (Reuters) - Croatian generic drugmaker Pliva, at the centre of a bid battle, said on Friday U.S. regulators had given a green light to three of its drugs after problems were fixed at production facilities in Zagreb.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
BIOSECURE Act
The BIOSECURE Act Is Back, as Congress Tacks New Version On to Broader Defense Bill
October 10, 2025
·
1 min read
·
Annalee Armstrong
Policy
NHS Mulls Greater Pharma Spending to Head Off Trump’s Tariffs: Report
October 10, 2025
·
2 min read
·
Tristan Manalac
Vaccines
ACIP Meeting Delayed Indefinitely; COVID-19 Vaccines Continue To Show Benefit in New Study
October 9, 2025
·
2 min read
·
Tristan Manalac
Government
Despite mRNA Vaccine Pullback, HHS Awards $48M for Kernal’s mRNA CAR T Program
October 8, 2025
·
2 min read
·
Tristan Manalac